Incyte
INCY
A$120.01
Share price
-0.40%
Change (1 day)
26.11%
Change (1 year)
Categories
Market capitalization of Incyte (INCY)
Market cap: A$23.43 Billion
As of August 2025 Incyte has a market cap of A$23.43 Billion. This makes Incyte the world's 1336th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Incyte from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | A$23.43 B | 9.29% |
| 2024 | A$21.44 B | 3.82% |
| 2023 | A$20.65 B | -21.34% |
| 2022 | A$26.25 B | 17.42% |
| 2021 | A$22.36 B | -9.72% |
| 2020 | A$24.77 B | -8.12% |
| 2019 | A$26.96 B | 40.05% |
| 2018 | A$19.25 B | -24.8% |
| 2017 | A$25.60 B | -2.3% |
| 2016 | A$26.20 B | -5.69% |
| 2015 | A$27.78 B | 82.03% |
| 2014 | A$15.26 B | 65% |
| 2013 | A$9.25 B | 333.68% |
| 2012 | A$2.13 B | 15.37% |
| 2011 | A$1.84 B | -8% |
| 2010 | A$2.00 B | 66.69% |
| 2009 | A$1.20 B | 130.98% |
| 2008 | A$0.52 B | -46.28% |
| 2007 | A$0.97 B | 56.2% |
| 2006 | A$0.62 B | 1.97% |
| 2005 | A$0.61 B | -43.08% |
| 2004 | A$1.07 B | 60.55% |
| 2003 | A$0.66 B | 22.78% |
| 2002 | A$0.54 B | -78.61% |
| 2001 | A$2.54 B | -13.01% |
| 2000 | A$2.92 B | 10.8% |
| 1999 | A$2.63 B | 55.27% |
| 1998 | A$1.69 B | 2.26% |
| 1997 | A$1.66 B | 145.3% |
| 1996 | A$0.67 B |
End of Day market cap according to different sources
On Aug 4th, 2025 the market cap of Incyte was reported to be:
A$23.52 Billion
A$23.52 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | A$249.13 B | 963.10% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | A$4.02 B | -82.82% | 🇺🇸 USA |
 Eli Lilly LLY | A$1.061 T | 4,430.43% | 🇺🇸 USA |
 Pfizer PFE | A$217.26 B | 827.10% | 🇺🇸 USA |
 Geron GERN | A$1.18 B | -94.96% | 🇺🇸 USA |
 Ardelyx ARDX | A$1.89 B | -91.91% | 🇺🇸 USA |
 Novartis NVS | A$351.88 B | 1,401.58% | 🇨🇭 Switzerland |
 AVEO Oncology
AVEO | A$0.80 B | -96.56% | 🇺🇸 USA |
 CTI BioPharma
CTIC | A$1.85 B | -92.10% | 🇺🇸 USA |